Clinical trials: Borderline Personality Disorders
- Condition Borderline Personality Disorders
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Borderline Personality Disorder
Olanzapine in Patients With Borderline Personality Disorder
The goals of this study are to determine: the safety of olanzapine and any side effects that might be associated with it, how olanzapine compares to placebo, whether olanzapine can help patients with symptoms of Borderline…
- Trial name
- NCT00091650
- Testing
- Olanzapine
- Where
- 39 sites in United States, Belgium and 7 more
- Volunteers
- 300 people
- Sponsor
- Eli Lilly and Company